Gapping down
In reaction to earnings/guidance:
- RDS.A -5.8% (provides update; adjusted Earnings are expected to show a loss in the current price environment )
M&A news:
- QEP -7.4% (to be acquired by Diamondback Energy in all-stock transaction)
- FANG -6.1% (entered into a definitive agreement under which Diamondback will acquire QEP (QEP) in an all-stock transaction valued at approximately $2.2 billion)
- RNET -3.8% (agrees to be acquired by Viasat (VSAT))
- THO -0.7% (announced the acquisition of Tiffin Motor Homes for $300 mln )
- LMT -0.6% (to acquire Aerojet Rocketdyne (AJRD)
Other news:
- QURE -18.4% (announced that its hemophilia B gene therapy program, including the pivotal, Phase III HOPE-B study, has been placed on clinical hold by FDA)
- FGEN -11.3% (provides regulatory update on roxadustat; NDA review period to be extended by three months )
- CPE -7.8% (files for 9,025,744 share common stock offering by selling shareholders)
- VALE -5.2% (informs on a landslide at the Córrego do Feijão mine)
- GSK -2.3% (announces the Marketing Authorisation of the first complete long-acting injectable HIV treatment in Europe)
- IMGN -2.1% (files for mixed securities shelf offering)
Analyst comments:
- TPR -6.1% (downgraded to Hold from Buy at HSBC Securities)
- APPS -5.2% (downgraded to Hold from Buy at Canaccord Genuity)
- MAC -4.9% (downgraded to Underweight from Neutral at JP Morgan)
- ARWR -4.3% (downgraded to Neutral from Outperform at Robert W. Baird)
- EPR -3.9% ( downgraded to Underweight from Neutral at JP Morgan)
- EPZM -3.1% (downgraded to Hold from Buy at Jefferies)
- VER -2.8% (downgraded to Neutral from Overweight at JP Morgan)
- BXP -1.3% (downgraded to Underweight from Neutral at JP Morgan)
- ICPT -1.2% (downgraded to Hold from Buy at Jefferies)